Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

Share Price is delayed by 15 minutes
Get Live Data
365.00    20.00 (5.80%)
Bid:
350.00
Ask:
380.00
Spread: 30.00 (8.571%)
Market Cap: £34.88m
CRPR Live PriceLast checked at - London Stock Exchange

Intraday Cropper (J) Share Chart

Trading Update

8 Feb 2012 07:00

RNS Number : 9872W
Cropper(James) PLC
08 February 2012
 



 

08 February 2012

 

 

James Cropper PLC ("the Company")

 

Investment in a new manufacturing facility in the USA and Trading Update

 

USA Investment

 

The Company is pleased to announce that it has authorised an initial investment of US$3m in a new manufacturing facility located at Rotterdam, New York State. The facility will include two fibre plating lines.

 

In late 2011 the Company's subsidiary Technical Fibre Products ("TFP") entered into a 10 year lease of a 50,000 square foot facility in Rotterdam in order to consolidate all of its US activities into one site as the current US manufacturing sites do not have the capacity or capability to meet the expected growing demand in a number of customer programmes in the aerospace, defence and electronic sectors. These are anticipated to generate significant long term revenues. TFP supplies specialist metal-coated fibres and non-woven material to the programmes mentioned above. Currently the primary manufacture of these materials takes place at TFP's existing US facilities in Cincinnati, OH and Stratford CT with secondary processing at the Company's main site in Kendal, UK.

 

The Cincinnati facility will close by mid-2012. It will take approximately 18 months for the facility at Rotterdam to attain accreditation to a number of important customer programmes which consume materials sourced from the Stratford facility. Once accreditation has been achieved the Stratford facility will also be closed. If current company projections are achieved it is anticipated that the Rotterdam facility will operate on a break-even in 2015.

 

Trading Update

 

As a consequence of this development costs totalling approximately £0.5 million relating to relocation and refurbishment will be expensed against profit in the current financial year. This cost has not been built into current market projections relating to TFP.

 

The reduced level of sales by James Cropper Speciality Papers ("Speciality Papers") anticipated in the Interim Statement has materialised both in UK and Euro-zone markets. James Cropper Converting ("Converting") has been similarly affected. Sales by Speciality Papers and Converting are now anticipated to be significantly down on previous projections.

 

Overall Company profit before tax, prior to IAS19 pension adjustment is now expected to be in line with last year.

 

Enquiries:

 

James Cropper PLC

John Denman, Group Finance Director

Tel: 01539 722 002

www.cropper.com 

 

Westhouse Securities Limited

Adam Lloyd

Paul Gillam

Tel: 020 7601 6100

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBKODDOBKDKBK
Date   Source Headline
14th Apr 20267:00 amRNSFull Year Trading Update
27th Mar 20262:50 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNS-RCollaboration with Hexcel on Composite Recycling
5th Dec 20259:34 amRNSHolding(s) in Company
2nd Dec 20257:00 amRNSPCA Shareholdings
17th Nov 20257:00 amRNSInterim Results
5th Nov 20257:00 amRNSNotice of Results and Investor Presentation
20th Oct 20257:00 amRNSCorrection: PDMR and PCA Shareholdings
17th Oct 20254:12 pmRNSPDMR and PCA Shareholdings
15th Sep 20257:00 amRNSDirector/PDMR Shareholding
3rd Sep 20253:34 pmRNSResult of AGM
3rd Sep 20257:00 amRNSAGM Trading Update
7th Aug 20257:00 amRNSNotice of Annual General Meeting
4th Aug 20257:00 amRNSGrant of Awards under Long-Term Incentive Plan
17th Jul 20257:00 amRNSFull Year Results
15th Jul 20257:00 amRNSNotice of Full Year Results
7th Jul 20257:00 amRNSTrading and Paper & Packaging Customer Update
23rd Jun 20257:00 amRNS-RRecording of Capital Markets Event Presentation
18th Jun 20257:00 amRNSStrategy Update and Capital Markets Event
9th Jun 20257:00 amRNSRevised Terms Agreed for UK Banking Facility
5th Jun 20257:00 amRNS-RNotice of Capital Markets Event
19th May 20257:00 amRNSDirector/PDMR Shareholding
12th May 20257:00 amRNSDirector/PDMR Shareholding
7th May 20257:00 amRNSFull Year Trading Update
1st May 20259:14 amRNS€1.75m sale of non-core IP assets
1st Apr 20257:00 amRNS-RStrategic Collaboration with HOERBIGER
14th Feb 20253:32 pmRNSDirector/PDMR Shareholding
3rd Feb 20257:00 amRNSPDMR and PCA Shareholding
30th Jan 20257:00 amRNSConfirmation of Chief Executive Officer Succession
7th Jan 20257:00 amRNSDirectorate Change
23rd Dec 20249:21 amRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSInterim Results
4th Nov 202412:03 pmRNSNotification of Major Holdings
1st Nov 20241:05 pmRNSNotice of Interim Results
29th Oct 20247:00 amRNSChief Executive Officer Succession
10th Oct 202410:14 amRNSDirector/PDMR Shareholding
8th Oct 20244:39 pmRNSDirector/PDMR Shareholding
10th Sep 20243:19 pmRNSGrant of Awards under Long-Term Incentive Plan
4th Sep 20244:32 pmRNSResult of Annual General Meeting
4th Sep 20247:00 amRNSAGM Trading Update
5th Aug 202411:56 amRNSNotice of Annual General Meeting
23rd Jul 20247:00 amRNSFull Year Results
22nd Jul 20249:43 amRNSDirectorate Changes
10th Jul 20247:00 amRNSNotice of Full Year Results
14th Jun 202411:00 amRNSAgreement of Bank Covenant Amendments
23rd May 20247:00 amRNSAppointment of MD, Advanced Materials
30th Apr 20247:00 amRNSFull Year Trading Update
12th Mar 20243:06 pmRNSDirector/PDMR Shareholding
8th Mar 20242:25 pmRNSDirector/PDMR Shareholding
17th Jan 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.